| 41.6525 -0.358 (-0.85%) | 09-18 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 52.3 | 1-year : | 54.89 |
| Resists | First : | 44.78 | Second : | 47 |
| Pivot price | 42.7 |
|||
| Supports | First : | 41.2 | Second : | 34.27 |
| MAs | MA(5) : | 41.72  |
MA(20) : | 43.22 |
| MA(100) : | 40.3 |
MA(250) : | 36.87 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 12.2 |
D(3) : | 10.6 |
| RSI | RSI(14): 42.5 |
|||
| 52-week | High : | 47 | Low : | 26.6 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ CANC ] has closed above bottom band by 24.7%. Bollinger Bands are 23.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 41.87 - 42.07 | 42.07 - 42.27 |
| Low: | 40.95 - 41.21 | 41.21 - 41.47 |
| Close: | 41.17 - 41.58 | 41.58 - 41.99 |
The Tema Oncology ETF (CANC) is designed to strategically invest in companies well-positioned to capitalize on significant advancements within cancer-focused biotechnology and the broader healthcare sector.
Fri, 04 Sep 2026
Discipline and Rules-Based Execution in CANC Response - Stock Traders Daily
Fri, 04 Sep 2026
TEMA ONCOLOGY ETF (CANC) Stock Chart - ChartMill
Wed, 26 Aug 2026
Why Healthcare Is Worth Revisiting as 2026 Draws to a Close - Tema ETFs
Thu, 20 Aug 2026
Biotech ETF (CANC) Hits New 52-Week High - Yahoo Finance
Sat, 15 Aug 2026
(CANC) Volatility Zones as Tactical Triggers - Stock Traders Daily
Tue, 14 Jul 2026
CANC ETF Profile: Dividends, Returns (NASDAQ:CANC) - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|